[Inborn errors of metabolism in adults]
- PMID: 19178907
- DOI: 10.1016/j.ando.2008.12.004
[Inborn errors of metabolism in adults]
Abstract
We present a simplified classification of treatable inborn errors of metabolism (IEM) in three groups with a special focus on those disorders observed at adult age. Group 1 includes inborn errors (IE) of intermediary metabolism which give rise to an acute or chronic intoxication. It encompasses aminoacidopathies, organic acidurias (OA), urea cycle disorders (UCD), sugar intolerances, metal storage disorders and porphyrias. Clinical expression can be acute, systemic or involves a specific organ, it can strike in the neonatal period or later and intermittently from infancy to late adulthood. Most of these disorders are treatable and require the emergency removal of the toxin by special diets, extracorporeal procedures, cleansing drugs or vitamins. Group 2 includes IE of intermediary metabolism which affect the cytoplasmic and mitochondrial energetic processes. Cytoplasmic defects encompass those affecting glycolysis, glycogenosis, gluconeogenesis, creatine and pentose phosphate pathways; the latter are untreatable. Mitochondrial defects include respiratory chain disorders, Krebs cycle and pyruvate oxidation defects, mostly untreatable, and disorders of fatty acid oxidation and ketone bodies that are treatable. Group 3 involves cellular organelles and include lysosomal, peroxisomal, glycosylation, and cholesterol synthesis defects. Among these, some lysosomal disorders can be efficiently treated by enzyme replacement or substrate reduction therapies. Physicians can be faced with the possibility of a treatable IE in emergency, either in the neonatal period or late in infancy to adulthood, or as chronic and progressive symptoms, general (failure to thrive), neurological, or specific for various organs or systems. These symptoms and the simplified classification of IEM are summarized in seven tables.
Similar articles
-
Clinical approach to treatable inborn metabolic diseases: an introduction.J Inherit Metab Dis. 2006 Apr-Jun;29(2-3):261-74. doi: 10.1007/s10545-006-0358-0. J Inherit Metab Dis. 2006. PMID: 16763886 Review.
-
[Inborn errors of metabolism in adult neurology].Rev Neurol (Paris). 2013 Feb;169 Suppl 1:S63-9. doi: 10.1016/S0035-3787(13)70062-6. Rev Neurol (Paris). 2013. PMID: 23452774 Review. French.
-
Clinical neurogenetics: neurologic presentations of metabolic disorders.Neurol Clin. 2013 Nov;31(4):1031-50. doi: 10.1016/j.ncl.2013.04.005. Epub 2013 Aug 8. Neurol Clin. 2013. PMID: 24176422 Review.
-
[Clinical presentation of inborn metabolic diseases in the neonatal period].Arch Pediatr. 2012 Sep;19(9):953-8. doi: 10.1016/j.arcped.2012.06.008. Epub 2012 Aug 9. Arch Pediatr. 2012. PMID: 22877859 French.
-
Proposal for a simplified classification of IMD based on a pathophysiological approach: A practical guide for clinicians.J Inherit Metab Dis. 2019 Jul;42(4):706-727. doi: 10.1002/jimd.12086. Epub 2019 Apr 24. J Inherit Metab Dis. 2019. PMID: 30883825
Cited by
-
Hormonal dysfunction in adult patients affected with inherited metabolic disorders.J Mother Child. 2020 Nov 10;24(2):21-31. doi: 10.34763/jmotherandchild.20202402si.2018.000005. J Mother Child. 2020. PMID: 33179602 Free PMC article. Review.
-
Cardiac manifestations in adult patients with inherited metabolic disease: A single-center experience.Mol Genet Metab Rep. 2025 Apr 11;43:101216. doi: 10.1016/j.ymgmr.2025.101216. eCollection 2025 Jun. Mol Genet Metab Rep. 2025. PMID: 40276563 Free PMC article.
-
Endocrine manifestations related to inherited metabolic diseases in adults.Orphanet J Rare Dis. 2012 Jan 28;7:11. doi: 10.1186/1750-1172-7-11. Orphanet J Rare Dis. 2012. PMID: 22284844 Free PMC article. Review.
-
Transition of young adults with endocrine and metabolic diseases: the 'TRANSEND' cohort.Endocr Connect. 2021 Jan;10(1):21-28. doi: 10.1530/EC-20-0520. Endocr Connect. 2021. PMID: 33263561 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources